Mesa Laboratories, Inc.Mesa Laboratories, Inc.Mesa Laboratories, Inc.

Mesa Laboratories, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪722.71 M‬USD
−45.54USD
‪−254.25 M‬USD
‪216.19 M‬USD
‪5.21 M‬
Beta (1Y)
1.55
Employees (FY)
736
Change (1Y)
+38 +5.44%
Revenue / Employee (1Y)
‪293.73 K‬USD
Net income / Employee (1Y)
‪−345.44 K‬USD

About Mesa Laboratories, Inc.


CEO
Gary M. Owens
Headquarters
Lakewood
Founded
1982
FIGI
BBG000BP3PW7
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MLAB is 130.80 USD — it has decreased by −1.89% in the past 24 hours. Watch Mesa Laboratories, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mesa Laboratories, Inc. stocks are traded under the ticker MLAB.
MLAB stock has risen by 2.55% compared to the previous week, the month change is a 13.45% rise, over the last year Mesa Laboratories, Inc. has showed a 22.83% increase.
We've gathered analysts' opinions on Mesa Laboratories, Inc. future price: according to them, MLAB price has a max estimate of 150.00 USD and a min estimate of 130.00 USD. Watch MLAB chart and read a more detailed Mesa Laboratories, Inc. stock forecast: see what analysts think of Mesa Laboratories, Inc. and suggest that you do with its stocks.
MLAB reached its all-time high on Dec 28, 2021 with the price of 333.42 USD, and its all-time low was 0.25 USD and was reached on Oct 7, 1987. View more price dynamics on MLAB chart.
See other stocks reaching their highest and lowest prices.
MLAB stock is 1.94% volatile and has beta coefficient of 1.55. Track Mesa Laboratories, Inc. stock price on the chart and check out the list of the most volatile stocks — is Mesa Laboratories, Inc. there?
Today Mesa Laboratories, Inc. has the market capitalization of ‪722.71 M‬, it has increased by 0.97% over the last week.
Yes, you can track Mesa Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Mesa Laboratories, Inc. is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
MLAB earnings for the last quarter are 2.62 USD per share, whereas the estimation was 1.89 USD resulting in a 38.62% surprise. The estimated earnings for the next quarter are 1.91 USD per share. See more details about Mesa Laboratories, Inc. earnings.
Mesa Laboratories, Inc. revenue for the last quarter amounts to ‪57.83 M‬ USD, despite the estimated figure of ‪57.88 M‬ USD. In the next quarter, revenue is expected to reach ‪58.70 M‬ USD.
MLAB net income for the last quarter is ‪3.43 M‬ USD, while the quarter before that showed ‪3.39 M‬ USD of net income which accounts for 1.18% change. Track more Mesa Laboratories, Inc. financial stats to get the full picture.
Yes, MLAB dividends are paid quarterly. The last dividend per share was 0.16 USD. As of today, Dividend Yield (TTM)% is 0.48%. Tracking Mesa Laboratories, Inc. dividends might help you take more informed decisions.
As of Dec 30, 2024, the company has 736.00 employees. See our rating of the largest employees — is Mesa Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mesa Laboratories, Inc. EBITDA is ‪40.88 M‬ USD, and current EBITDA margin is 16.78%. See more stats in Mesa Laboratories, Inc. financial statements.
Like other stocks, MLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mesa Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mesa Laboratories, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mesa Laboratories, Inc. stock shows the neutral signal. See more of Mesa Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.